Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoya Sakamoto

Showing results (1-10 of 899) with videos related to

Pageof 90
Sort By:
Journal of Gastroenterology and Hepatology|April 26, 2013
NX-PVKA assay, a conventional but refined prognostic biomarker for hepatocellular carcinomaNaoya Sakamoto
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 16, 2016
[Progress in Diagnostic Technology and Management of Infectious Diseases. Special Columns; Domestic dengue virus infection]Naoya Sakamoto
[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science|July 22, 2014
[Future perspectives of hepatitis C therapeutics]Naoya Sakamoto
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|March 26, 2008
[Anti-viral therapy of type C chronic hepatitis. 2. Progression of type C chronic hepatitis and resistance to treatment. 1) From a viewpoint of viral mutation]Naoya Sakamoto
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 21, 2016
[Programs for Continuing Medical Education: A session; 1. New therapeutic strategies for hepatitis C by direct-acting antivirals (DAA)]Naoya Sakamoto
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|January 9, 2016
Standard antiviral therapies against HCV infectionNaoya Sakamoto
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|June 11, 2025
[Debrief of the 66th Annual Meeting of the Japanese Society of Gastroenterology]Naoya Sakamoto
Internal Medicine (Tokyo, Japan)|October 15, 2020
Angiogenic Dreaded Killer: Cholesterol Crystal EmbolizationMasaki Kuwatani, Naoya Sakamoto
Endoscopic Ultrasound|June 26, 2020
Evolution and a promising role of EUS-FNA in gene and future analysesMasaki Kuwatani, Naoya Sakamoto
Journal of Gastroenterology|May 21, 2009
New therapeutic approaches to hepatitis C virusNaoya Sakamoto, Mamoru Watanabe
Pageof 90

Showing results (1-10 of 899) with videos related to

Sort By:
Pageof 90
Journal of Gastroenterology and Hepatology|April 26, 2013
NX-PVKA assay, a conventional but refined prognostic biomarker for hepatocellular carcinomaNaoya Sakamoto
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 16, 2016
[Progress in Diagnostic Technology and Management of Infectious Diseases. Special Columns; Domestic dengue virus infection]Naoya Sakamoto
[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science|July 22, 2014
[Future perspectives of hepatitis C therapeutics]Naoya Sakamoto
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|March 26, 2008
[Anti-viral therapy of type C chronic hepatitis. 2. Progression of type C chronic hepatitis and resistance to treatment. 1) From a viewpoint of viral mutation]Naoya Sakamoto
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 21, 2016
[Programs for Continuing Medical Education: A session; 1. New therapeutic strategies for hepatitis C by direct-acting antivirals (DAA)]Naoya Sakamoto
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|January 9, 2016
Standard antiviral therapies against HCV infectionNaoya Sakamoto
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|June 11, 2025
[Debrief of the 66th Annual Meeting of the Japanese Society of Gastroenterology]Naoya Sakamoto
Internal Medicine (Tokyo, Japan)|October 15, 2020
Angiogenic Dreaded Killer: Cholesterol Crystal EmbolizationMasaki Kuwatani, Naoya Sakamoto
Endoscopic Ultrasound|June 26, 2020
Evolution and a promising role of EUS-FNA in gene and future analysesMasaki Kuwatani, Naoya Sakamoto
Journal of Gastroenterology|May 21, 2009
New therapeutic approaches to hepatitis C virusNaoya Sakamoto, Mamoru Watanabe
Pageof 90